Definitive Contract 75N95022C00040
Award Date
9/23/22
Potential Completion Date
6/22/23
Potential Value
$325K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Biosensics LLC
Ultimate Awardee
Not listed
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Newtonville, MA 02458, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
7
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Biosensics LLC, a small business, has been awarded a $2,000,000.00 firm fixed price definitive contract by the National Institutes of Health's National Center for Advancing Translational Sciences. The contract is for Technological Development and Validation of Remote Measures for Use in Clinical Trials in Individuals with Rare Diseases, under the Small Business Innovation Research (SBIR) program. Biosensics LLC specializes in wearable devices for monitoring physical activity, gait, balance,...
This is a $400,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Biosensics LLC, a small business located in Newtonville, Massachusetts. The contract is for the development of an automated screening platform to enable early identification of malnutrition in cancer patients. This contract award is part of the FY24 SBIR solicitation, which covers a variety of research topics...
This federal contract award to Biosensics LLC is a STTR Phase I contract with a ceiling value of $149,997.80. The contract was awarded by the U.S. Army Medical Command, a defense agency, and is designated as a total small business set-aside. The contract is for research and development work related to developing innovative wearable sensor platforms, cloud-based software solutions, and remote monitoring technologies for healthcare applications. Biosensics LLC is a small business that...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Advanced Silicon Group, Inc., a woman-owned small business. The contract, valued at $400,000.00, is for research and development of a biosensor prototype that can detect drugs in postmortem blood samples using coupled acoustical wave micropillar technology. The contract is a firm fixed-price definitive contract with a completion date of...
The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded a $499,998.00 Small Business Innovation Research (SBIR) Phase I contract to Vivonics Inc., a medical technology company based in Bedford, Massachusetts. The contract is for the development of a wearable biosensor for alcohol monitoring. As a small business, this award was set aside for small business concerns. Vivonics is an experienced federal contractor,...
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Drug Abuse awarded a Small Business Innovation Research (SBIR) Phase I contract to Portable Diagnostic Systems Inc. in Robbinsville, New Jersey. The contract, with a potential value of $400,000.00, is for the development of an ultraportable lab-on-a-chip biosensor system for rapid postmortem toxicology. The period of performance is September 27, 2023 to September 26, 2024, and the...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Lifesensors Inc., doing business as Gene Transcription TECH. The contract is for applied/exploratory biomedical research, with a ceiling value of $149,550 and a period of performance through March 30, 2010. Lifesensors is a biotechnology company that conducts research on novel therapeutic approaches such as targeted...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a $224,759 Firm Fixed Price contract to Litmus Health, Inc., a small business, to develop an extensible and scalable platform for data integration from wearable sensors to generate novel analytics for cancer patients. This award is associated with the NIH/Centers for Disease Control and Prevention (CDC) Small Business Innovation Research (SBIR) Program Solicitation PHS...
<p>This is a federal contract award from the National Heart Lung and Blood Institute, a civilian agency, to Biomedomics, Inc., a minority-owned, for-profit manufacturer of goods, for a Small Business Innovation Research (SBIR) Program Phase I research project. The contract has a Firm Fixed Price of $99,932.00 and was awarded on December 1, 2009 with a completion date of May 31, 2010. The contract is set aside for small businesses. No additional subcontractors or context are provided.</p>
This definitive contract from the Department of Health and Human Services' National Institutes of Health and National Heart Lung and Blood Institute awarded $399,917 to Transmural Systems LLC. The firm fixed price contract supports research under the Small Business Innovation Research Program's Phase I topic for developing an MRI myocardial biopsy system. The work will take place in Andover, Massachusetts from September 2020 through December 2021. This total small business set-aside award...